Arylsulfonylchromans as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors

摘要

Disclosed is a sulfonyl-chroman compound of formula I or a pharmaceutically acceptable salt, an individual optical isomer, a racemic or non-racemic mixture thereof wherein m is 2 and wherein the substituents are as disclosed in the specification. Also disclosed is the process of making a compound of formula I and the use of the compound of formula I wherein the medicament is useful in the treatment or prevention of central nervous system diseases.